Author

Gareth Parkes 1

1 Barts Health NHS Trust, London, United Kingdom

BENEFITS OF HIGH VERSUS LOW DOSE UPADACITINIB AS MAINTENANCE TREATMENT IN ULCERATIVE COLITIS PATIENTS WHO WERE RESPONDERS TO 8-WEEK INDUCTION WITH UPADACITINIB: RESULTS FROM THE U-ACHIEVE PHASE 3 MAINTENANCE TRIAL

Brian G. Feagan, Gareth Parkes, Pascal Juillerat, Krisztina Barbara Gecse, Xuan Yao, Wen Zhou, Huiwen Deng, Dapo Ilo, Yuri Sanchez Gonzalez, Peter D.R. Higgins

MY IBD CARE, A DIGITAL THERAPEUTIC FOR IBD, IS SAFE AND EFFECTIVE: CASE-CONTROL STUDY IN TWO UK CENTRES

Gareth Parkes

MY IBD CARE, A DIGITAL THERAPEUTIC FOR IBD, IS SAFE AND EFFECTIVE: CASE-CONTROL STUDY IN TWO UK CENTRES

Gareth Parkes, Bu Hayee, Nanna Asgeirsdottir, Nader Alaghband, Ana Ibarra, Anouk Lehmann, Lucy Medcalf

PATIENT-REPORTED BURDEN OF CORTICOSTEROID USE IN INFLAMMATORY BOWEL DISEASE IN THE UK: RESULTS FROM THE DETERMINANTS, INCIDENCE AND CONSEQUENCES OF CORTICOSTEROID EXCESS (DICE) IMPACT QUESTIONNAIRE

Eman Al Sulais, Gareth Parkes, Krisztina B. Gecse, Tricia Finney-Hayward, Christian P. Selinger, Tim Raine

PATTERNS OF CORTICOSTEROID EXPOSURE AND EXCESS IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE DETERMINANTS, INCIDENCE AND CONSEQUENCES OF CORTICOSTEROID EXCESS (DICE) ONLINE MONITORING TOOL

John Wye, Edouard Louis, Stephane NANCEY, Irina Blumenstein, Revital Barkan, Walter Fries, Fernando Gomollón, Aykut Ferhat Çelik, Christian P. Selinger, Gareth Parkes, Tricia Finney-Hayward, Tim Raine

Item 1 - 5 / 5
1